Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- A Solution for Rising Drug Costs
- With the cost of prescription drugs rising at an alarming rate, employers are likely to ask employees to foot a greater percentage of pharmacy benefits bills. However, the tight labor market may make it hard for employers to get workers to accept coinsurance plans. Besides limiting coverage, employers can cut...
- White papers 2001-01-24
- Economic & Business Focus: Retiree Health Plans
- Recent Medicare legislation in the U.S. may force many companies to cancel prescription drug coverage for their retirees. Senior Finance Executives SFE must begin to address the potential impact of the new law on the retiree health plans and should decide upon the prescription drug provisions. The paper outlines the...
- White papers 2004-03-01
- The New Medicare Prescription Drug Law
- The Medicare Prescription Drug Improvement and Modernization Act the Act, makes prescription drug coverage available to all senior citizens for the first time ever beginning in 2006.Tthe costs of such plans have recently risen by nearly 20 percent a year, causing some companies to limit drug benefits under retiree health...
- White papers 2004-05-07
- Prescription Drugs and the Changing Patterns of Treatment for Mental Disorders
- This white paper uses detailed data on prescription drug and other services from the Medical Expenditure Panel Survey MEPS to examine recent trends in mental health and substance abuse (MH/SA) treatment between 1996 and 2001. While use of ambulatory services remained constant, prescription drug use increased rapidly, with the result...
- White papers 2004-12-09
- The Facts About Medicare-Approved Drug Discount Cards
- Medicare is contracting with private companies to offer Medicare-approved drug discount cards. People can choose one of the discount cards offered by these private companies, to help them save on outpatient prescription drugs. Almost anyone with Medicare can get a discount card. The only people who aren't eligible are those...
- White papers 2004-04-01
- Does Cost Sharing Affect Compliance? The Case of Prescription Drugs
- Private insurance for prescription drugs is characterized by two regimes: flat copayments and variable co-insurance. The paper develops a simple model to show that patient compliance is lower under coinsurance due to uncertainty in cost-sharing. Empirically, it derives comparable models for compliance behavior in the two regimes. Using claims data...
- White papers 2004-08-01
- Prescription Drug Prices: Why Do Some Pay More Than Others Do?
- This paper offers an analysis aimed at understanding pricing patterns of brand-name prescription drugs. It focuses on the basic economic forces that enable differential pricing of products to exist and show how features of the prescription drug market promote such phenomena. The analysis directs policy attention toward how purchasing practices...
- White papers 2001-10-30
- Using Evidence to Make Formulary Decisions for Rx Benefits
- A key component in the strategy to improve the overall health of employees is the prescription drug benefit, since those drugs are important in the prevention and treatment of many diseases. With this in mind, some employers are promoting appropriate prescription drug use by basing their prescription drug benefit plan...
- White papers 2005-05-16
- Pharmaceuticals: State Departments That Purchase Prescription Drugs Can Further Refine Their Cost Savings Strategies
- This report examines the purchasing strategies of the three primary departments that contract for prescription drugs- the Department of General Services General Services, the Department of Health Services Health Services, and the California Public Employees' Retirement System CalPERS. These departments procured more than $5 billion in prescription drugs during fiscal...
- White papers 2005-05-01
- Managing the Intricate Web of Prescription Drugs
- Prescription drug costs are the fastest rising component of health care and are contributing to the dramatic increase in health care costs. Emergence of generic drugs, employer recognition, and increased consumer knowledge are already forcing enormous change on the industry. This article explains the factors affecting the current financial pressure...
- White papers 2002-12-26
- Comparative Analysis of Medicare Discount Card Prices and Retail Prescription Drug Prices: November 2003 and July 2004
- The purpose of this study is to analyze changes in average retail prices and savings from average retail prices under the new Medicare prescription drug discount program for a 30-day supply of specific drug products commonly used by Medicare beneficiaries. The study compares retail cash prices obtained from Verispan with...
- White papers 2004-10-05
- Medicare Prescription Drugs: Making the New Program Work
- This article reports on the progress that has been made and questions that have been raised about the new Medicare prescription drug benefit that became law in late 2003. The focus is on issues raised during the National Medicare Prescription Drug Congress held in Washington, DC, in February 2004. The...
- White papers 2004-06-01
- Prescription Drugs: Recent Trends in Utilization, Expenditures, and Coverage
- Prescription drug costs, which rose by 15.7 percent in 2001, are the fastest rising component of medical expenditures and accounted for 16.7 percent of the total increase in health care spending that year. Americans spent more than $140 billion on prescription drugs in 2001-or about 10 percent of the nation's...
- White papers 2004-01-01
- Retiree Health Benefits: Options for Employment-Based Prescription Drug Benefits Under the Medicare Modernization Act
- The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 MMA created a prescription drug benefit for beneficiaries, called Medicare part D, beginning in January 2006. The paper determines the trends in employment-based retiree health coverage prior to the MMA and which MMA prescription drug options plan sponsors said they...
- White papers 2005-02-01
- Prescription Drugs: Preliminary Observations on Efforts to Enforce the Prohibitions on Personal Importation
- American consumers are increasingly drawn to the convenience, privacy, and cost advantages that might be accrued by purchasing prescription drugs over the Internet. The Department of Homeland Security's U.S. Customs and Border Protection CBP and the Department of Health and Human Service's Food and Drug Administration FDA are responsible for...
- White papers 2004-07-22
- Prescription Drugs: Price Trends for Frequently Used Brand and Generic Drugs From 2000 Through 2004
- Prescription drug spending has been the fastest growing segment of national health expenditures. As the federal government assumes greater financial responsibility for prescription drug expenditures with the introduction of Medicare part D, federal policymakers are increasingly concerned about prescription drug prices. The report examines the change in retail prices and...
- White papers 2005-08-01
- States' Control of Prescription Drug Spending: A Heterogeneous Approach
- In an effort to balance Medicaid budgets, states use prescription drug cost containment tools in unique ways and in varying combinations. The paper reports on the variability in state-level strategies to control the cost of prescription drugs and describes broad state-to-state differences in per beneficiary spending on drugs. This heterogeneity...
- White papers 2005-08-01
- Medicaid Cost Containment and Access to Prescription Drugs
- States have been intensifying their efforts to control rising prescription drug costs in their Medicaid programs. This study examines the effects of five Medicaid cost containment policies on enrollees' perceptions of their ability to get prescription drugs. The results show that enrollees in states that have implemented all or almost...
- White papers 2005-06-01
- Our Money and Our Lives: Medications and Health Policy
- With annual spending for prescription drugs escalating dramatically and with the percentage of elderly people also increasing, this paper provides a useful guide to the complexities of prescription drug development, testing, approval, coverage, and surveillance which is well timed. It brings considerable skills of the clinician and epidemiological researcher to...
- White papers 2005-08-01
- Competition: An Antidote to the High Price of Prescription Drugs
- Patent protection and factors unique to prescription drugs weaken the forces keeping prices near costs for other products. A growing public consensus that affordable drugs should be available to all is likely to increase the upward pressure on prices. To restore competition to all parts of the pharmaceutical industry, this...
- White papers 2004-08-01
- << Previous
- page 1 of 2
- Next >>
Refining Tags
- Medicare (7 results)
- Benefits (7 results)
- Human Resources (7 results)
- Health Care (6 results)
- Vertical Industries (6 results)
- Project HOPE (5 results)
- Enterprise Software (5 results)
- Software (5 results)
- Prescription (3 results)
- Pricing Strategy (3 results)
- Pricing (3 results)
- Marketing Research (3 results)
- Marketing (3 results)
